Supplementary Figure S2. (A-D) The correlation analyses of the ability of blood and tumor-derived FcR+ effectors to regulate A431 tumor cell growth in the presence of anti-EGFR Abs with key clinical parameters of lung cancer patients including tumor type, stage, size, and smoking history. The effect of FcR+ effectors on A431 tumor cell growth was evaluated in the IncuCyte® Live Cell Analysis System. AC-adenocarcinoma, SCC-squamous cell carcinoma. Pearson test. Number of patients included in each analysis is indicated on the graphs.
No takes yet. Share an insight, caveat, or question.
Singhal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: